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Abstract The dentin sialophosphoprotein (DSPP) gene
(4q21.3) encodes two major noncollagenous dentin matrix
proteins: dentin sialoprotein (DSP) and dentin phospho-
protein (DPP). Defects in the human gene encoding DSPP
cause inherited dentin defects, and these defects can be
associated with bilateral progressive high-frequency sen-
sorineural hearing loss. Clinically, five different patterns of
inherited dentin defects are distinguished and are classified
as dentinogenesis imperfecta (DGI) types I, II, and III, and
dentin dysplasia types I and II. The genetic basis for this
clinical heterogeneity is unknown. Among the 11
members recruited from the studied kindred, five were
affected with autosomal dominant DGI type II. The
mutation (g.1188C→G, IVS2-3C→G) lay in the third
from the last nucleotide of intron 2 and changed its
sequence from CAG to GAG. The mutation was correlated
with the affection status and was absent in 104 unaffected
individuals (208 alleles) with the same ethnic and
geological background. The proband was in the primary
dentition stage and presented with multiple pulp expo-
sures. The occlusal surface of his dental enamel was
generally abraded, and the dentin was heavily worn and
uniformly shaded brown. The dental pulp chambers
appeared originally to be within normal limits without
any sign of obliteration, but over time (by age 4), the pulp
chambers became partially or completely obliterated. The
oldest affected member (age 59) showed mild hearing loss
at high-frequency (8 kHz). Permanent dentition was
severely affected in the adults, who had advanced dental
attrition, premature loss of teeth, and extensive dental
reconstruction.
Introduction
Dentin forms in an extracellular space, the contents of
which are determined by odontoblasts, the cells that line
the space and extend cellular processes into the dentin.
Odontoblasts secrete type I collagen and highly specia-
lized proteins that typically contain extensive post-trans-
lational modifications, such as glycosylations, phosphor-
ylations, and glycosaminoglycans. These molecules are
believed to control the size, shape, structure, and orien-
tation of the mineral that forms and bring the process of
mineralization under genetic control (Mann et al. 1989).
Tooth formation is a complex developmental process that
occurs as the result of a series of epithelial-mesenchymal
interactions (Thesleff 2003; Thesleff and Jernvall 1997;
Thesleff and Sharpe 1997; Tucker and Sharpe 1999).
Genetic disturbances early in tooth formation can arrest
tooth development. In humans, partial tooth agenesis
(oligodontia) occurs in assorted patterns and is caused by
defects in regulatory genes, usually encoding transcription
factors (Miletich and Sharpe 2003; Vastardis 2000).
Mutations in Msx1 (Vastardis et al. 1996) and Pax9
(Lammi et al. 2003; Stockton et al. 2000) result in
characteristic patterns of oligodontia. When the affected
regulatory gene is also involved in developmental
processes other than tooth formation, the resulting familial
tooth agenesis is a feature of a larger syndrome, such as
ectodermal dysplasia (Bayes et al. 1998; Kere et al. 1996)
or Rieger syndrome (Semina et al. 1996). Isolated
malformations are believed to occur exclusively within
the dental hard tissues only when genetic defects are
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manifested late in tooth formation, viz., during matrix
deposition and calcification. As a consequence, candidate
gene approaches to characterize the specific etiologies of
dentinogenesis imperfecta (DGI) and dentin dysplasia
(DD) focus on mutational analyses of the genes encoding
dentin matrix proteins.
Type I collagen is the predominant protein in dentin and
constitutes about 90% of the organic matrix (Linde 1989).
Mutations in COL1A1 or COL1A2, encoding type I
procollagen, cause more than 90% of osteogenesis imper-
fecta (OI), an autosomal dominant condition that primarily
affects bone (Gajko-Galicka 2002). Each type of OI is
subdivided based upon the presence or absence of DGI
(DGI type I). The prevalence of DGI in OI patients has
been reported to be 20%–73%. The incidence of DGI is
highest in OI types III and IV. In OI type I, there is a great
discrepancy in the reported incidence, varying from 8% to
40% (Malmgren and Lindskog 2003). Occasionally,
reduced penetrance and the mildness of the skeletal
features make DGI the predominant clinical feature that
initially leads clinicians to the diagnosis of OI (Pallos et al.
2001).
The major noncollagenous proteins of dentin are dentin
sialoprotein (DSP) and dentin phosphoprotein (DPP;
Dimuzio and Veis 1978; Leaver et al. 1975; Linde et al.
1980; Veis and Perry 1967), which are encoded by the
dentin sialophosphoprotein (DSPP) gene (Ritchie et al.
1996). Despite being translated from a single open reading
frame (MacDougall et al. 1997), the DSPP chimeric
protein has never been detected in dentin extracts and may
be processed by proteases into DSP and DPP prior to
secretion (Qin et al. 2003). DSP and DPP were originally
believed to be dentin-specific proteins (Butler 1987,
1992), until DSPP mRNA was detected in the inner ear
of mice by the reverse transcriptase/polymerase chain
reaction method (RT-PCR) after hearing defects were
discovered in DGI patients with mutations in the DSPP
gene (Xiao et al. 2001). Analyses of bone protein extracts
have since shown that the DSPP gene is generally
expressed in bone, but at lower levels than in dentin
(Butler et al. 2003; Qin et al. 2002, 2003). Whereas dentin
and bone appear to contain a similar inventory of
noncollagenous proteins, there are typically important
differences in quantity and proteolytic processing. DSP
and DPP appear to be the only extracellular constituents
that are more abundant in dentin than in bone (Qin et al.
2001).
Historically, the dentin defect associated with OI has
been classified as DGI type I, whereas isolated inherited
dentin defects have been categorized as DGI types II and
III and DD types I and II (Bixler 1976; Shields et al. 1973)
that vary according to the severity of the dental phenotype.
The phenotypic differences that have been used in this
classification system and to make clinical diagnoses,
however, do not appear to correlate with differences in
their genetic etiologies. The seven DSPP mutations
reported to date (Fig. 1) have been shown to cause DGI
type II (Malmgren et al. 2004; Xiao et al. 2001; Zhang et
al. 2001), DGI type II with deafness (Xiao et al. 2001),
and DD type II (Rajpar et al. 2002). In each case, the
pattern of inheritance is autosomal dominant. In addition,
DSPP-null mice develop tooth defects similar to those
seen in human DGI type III (Sreenath et al. 2003).
Although there are other candidate genes for inherited
malformations exclusive to dentin, no disease-causing
mutations outside of the DSPP gene have yet been
Fig. 1 DSPP mutations associated with inherited dentin defects.
The structure of the human DSPP gene is shown top. The exons are
represented as blocks numbered 1–5, with the amino acid numbers
(in parentheses) encoded by each exon being shown below. The
introns are represented by lines. The number of nucleotides in each
exon and intron is shown below. The locations of DSPP mutations
are indicated above the gene structure. Asterisk Mutation associated
with progressive hearing loss, X nonsense mutation. The lower box
summarizes the exon number, effect on the protein, location in
genomic and cDNA sequences, diagnosis and appropriate reference
(Malmgren et al. 2004; Xiao et al. 2001; Zhang et al. 2001; Rajpar et
al. 2002) for each mutation reported for the human DSPP gene
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identified. Here, we report a novel splice junction
mutation, viz., a C to G transversion, that lies in the
third from the last nucleotide of intron 2 and that causes
DGI type II in a Korean family.
Materials and methods
Enrollment of human subjects
The study protocol and subject consent were reviewed and approved
by the Institution Review Boards at the University of Michigan and
Seoul National University. Appropriate informed consent was
obtained from all subjects.
Fig. 2a–g Oral photographs and panorex radiographs from the DGI
kindred. Oral photographs show the dentition of the proband (IV-1)
at age 4.5 (a–c). All of the primary teeth show a consistent shade of
brown and almost complete attrition of the enamel layer. Panorex
radiographs of the proband taken at ages two (e) and 4.5 (f) are
shown right. All of the maxillary teeth required endodontic therapy
to treat or prevent pulp exposures and dental abscess formation
secondary to rapid attrition of the protective enamel and dentin
layers. An oral photograph shows the permanent dentition of an
affected adult family member (III-9) at age 27 (d). The highly
abraded teeth of this patient were covered with a removable partial
overdenture anchored to posterior molars restored with full crowns.
Hearing tests of four affected family members (g) showed mild
bilateral high-frequency hearing loss in subject II-4 at age 59. Air-
bone gaps were within normal limits (data not shown)
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Primer design
Oligonucleotide primers for PCR were designed by using Primer3
on the web (http://www-genome.wi.mit.edu/cgi-bin/primer/pri-
mer3_www.cgi). The strategy was to generate PCR amplification
products that would allow DNA sequencing of human DSPP exons
1–4 and about 50 bp of the adjoining intron sequence on both sides
of each exon. The primer pairs used for PCR amplification of
genomic DNA were: exon 1 (565-bp amplification product), sense
5′-tcaccaagtgaaggaagtgg and antisense 5′-aaagcccaaggtggattttt; exon
2 (596-bp amplification product), sense 5′-gatgtccccataaccacacc and
antisense 5′-ctccatgacttctgggcatt; exon 3–4 (1,482-bp amplification
product), sense 5′-caagccctgtaagaagccact and antisense 5′-acatg-
gatgcttgtcatggt.
PCR protocol
A 10-cm3 volume of peripheral whole blood was obtained from
participating family members. Genomic DNAwas isolated by means
of the QIAamp DNA Blood Maxi Kit (Qiagen, Valencia, Calif.,
USA). PCR amplifications were performed by using Platinum Taq
High Fidelity (Invitrogen, Carlsbad, Calif., USA). The reactions had
a 5-min denaturation at 94°C, followed by 40–50 cycles each with
denaturation at 94°C for 30 s, primer annealing at 56–58°C for 30 s,
and product extension at 72°C for 30–90 s. In the final cycle, the
72°C extension was for 7 min. PCR amplification products were
purified by the QIAquick PCR Purification Kit and protocol
(Qiagen).
DNA sequence analysis
DNA sequencing was performed at the University of Michigan
DNA Sequencing Core. The original PCR primers used to generate
each amplimer were employed for the sequencing reaction. In
addition, for the larger exon 3–4 amplification product, two sense
primers (5′-ggaccatgggaaagaagatg and 5′-gcatccagggacaagtaagc)
and three antisense oligonucleotides (5′-cattcccttctcccttgtga, 5′-
cctcgtttctacaggaattctca, 5′-tggaggtcttgtctccatca) were used for se-
quencing reactions.
Single-stranded conformational polymorphism analysis
Once the DSPP mutation was identified in intron 2, we designed
PCR primers for single-stranded conformational polymorphism
(SSCP) analysis (151-bp amplification product, sense 5′-
gtgtgcacgctcacacacat and antisense 5′-tgtactgacacatttgatcttgcta).
The PCR products were mixed with formamide loading buffer
(95% formamide with bromophenol blue and xylene cyanol), heated
to 95°C for 5 min, quenched on ice, and loaded onto a 15%
polyacrylamide gel. Electrophoresis was performed with a constant
ampere mode of 15 mA, and 250 V for 4 h.
Allele-specific oligonucleotide hybridization analysis
Two oligonucleotide probes, 20 nucleotides in length and differing
only at the position of the mutation identified by DNA sequencing,
were synthesized (wild-type 5′-tctacttggCaggttcctca; mutant 5′-
tctacttggGaggttcctca). Genomic DNA samples from 104 randomly
selected normal Korean subjects were amplified by using the PCR
primers designed for SSCP analysis. A 20-μl aliquot of each PCR
product was blotted onto a Zeta-probe nylon membrane (Bio-Rad
Laboratories, Richmond, Calif., USA) and hybridized with 10 pmol
of either the wild-type or the mutant oligonucleotide probe, which
was end-labeled with [γ−32P]ATP (6,000 Ci/mmol; MP Biomedical,
Irvine, Calif., USA) by using T4 polynucleotide kinase.
Results
The proband was a 2-year-old boy who presented with
dental features consistent with a diagnosis of DGI. His oral
and radiographic presentations are shown in Fig. 2. The
crowns of the primary teeth were uniformly shaded brown.
The dental enamel on the occlusal surfaces had worn away
and exposed the underlying softer malformed dentin to
rapid attrition. The dental pulp chambers appeared
originally to be within normal limits without any sign of
obliteration, but over time (by age 4), the pulp chambers
became partially or completely obliterated. Physical
examination revealed no rickets or other obvious skeletal
abnormalities. The permanent dentitions of affected older
individuals in this kindred were edentulous, extensively
restored, or showed attrition down to the level of the
gingiva, and were a uniform dark brown in color.
The family pedigree was determined and 11 members,
spanning three generations, were recruited for mutational
analyses (Fig. 3). DNA sequence analysis showed that the
proband had a mutation (CAG to GAG, g.1188C→G,
IVS2-3C→G) in the third nucleotide from the end of
intron 2 in one of his two DSPP alleles (the nucleotide
number for this mutation was determined by counting
from the first nucleotide of the translation initiation codon
of the human DSPP gene sequence, accession no.
AF163151). The intron 2/exon 3 junction was amplified
from the 11 recruited family members, and SSCP analysis
showed a unique band among the amplification products
from the five affected members only (Fig. 3). Allele-
specific oligonucleotide (ASO) hybridization analysis of
more than 200 DSPP alleles did not detect this mutation,
suggesting that this C to G transversion is not a common
polymorphism in the general Korean population. Although
a C in the −3 position of an intron splice acceptor is
generally favored (78% of GU-AG introns), a G is almost
never observed (Padgett et al. 1986). This C in the −3
position of intron 2 is conserved in the three DSPP genes
that have been characterized (Fig. 3). On the basis of these
findings, we concluded that the IVS2-3C→G mutation in
the DSPP gene causes DGI in this kindred.
Hearing tests were conducted on four of the affected
members of this kindred (Fig. 2g). Pure-tone audiometry
(air-conduction thresholds and bone-conduction thresh-
olds) and speech audiometry (speech detection thresholds
and speech reception thresholds) hearing tests were used.
Only the oldest member (age 59) showed mild bilateral
sensorineural hearing loss, which was at the highest
frequency tested (8 kHz).
Discussion
There are now eight point mutations, all dominant in their
patterns of inheritance, that have been identified in the
human DSPP gene in families with inherited dentin
defects. A p.Y6D mutation in the coding region for the
signal peptide results in a DD-II phenotype, which is
distinguishable from DGI-II by the lack of brown
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discoloration in the permanent dentition (Rajpar et al.
2002). This mutation (p.Y6D) appears to impede the
secretion of the DSPP protein, so that roughly half of the
normal amount of protein is secreted into the dentin
matrix. Point mutations in codons 17 and 18 (p.P17T and
p.V18F), which are two and three amino acids away from
the signal peptide cleavage site, respectively, produce the
DGI-II phenotype together with progressive sensorineural
high-frequency hearing loss (DFNA39/DGI1, MIM
605594; Xiao et al. 2001). These amino acid substitutions
might disrupt the folding of the DSP protein directly, or
indirectly by interfering with proper signal peptide cleav-
age. Proper DSPP expression could be critical for the
correct formation of the inner ear, but other factors may
also play a role in the maintenance of full hearing. Jaw
position is known to affect the shape of the inner ear
(Oliveira et al. 1992), and tooth loss, even in the absence
of DGI, can lead to hearing deficits (Lawrence et al. 2001;
Nagasaka et al. 2002). A person with DGI typically
experiences significant dental attrition and premature loss
of teeth, and consequently, a decrease in the occlusal
vertical dimension with altered jaw position during
chewing. Depending upon the degree of dental restoration,
a loss of occlusal vertical dimension in patients with
DGI1/DFNA39 is plausible and might have caused or
contributed to their bilateral progressive hearing loss.
It will be interesting to determine whether the progres-
sive hearing loss in patients with DSPP mutations causing
DGI can be prevented by dental restoration. We need to
know more about the role of DSPP in bone formation, the
possible inner ear deformities in patients with DSPP
mutations, and the contributions of premature tooth loss
and reduced occlusal vertical dimension in patients with
inherited defects in the DSPP gene before we can
understand why some DSPP mutations are associated
with hearing loss while others are not. In this family, the
59-year-old affected person with no noise exposure history
showed mild bilateral sensorineural high-frequency hear-
ing loss. As this condition often accompanies aging, the
association (if any) of this hearing loss with the DSPP
mutation cannot be determined.
We have identified a novel point mutation that lies in
the RNA splicing acceptor site in intron 2 causing the
DGI-II phenotype and possibly progressive high-frequen-
cy sensorineural hearing loss. Introns can be divided into
different groups according to their properties (Clark and
Thanaraj 2002). Intron 2 of the human DSPP gene belongs
to group A3, because its donor site sequence starts with
GTA (A in the +3 position). This intron has a phase of zero
(occurs between codons), a length of 1,139 nucleotides,
and in the wild-type, a CAGGT acceptor site sequence at
positions −3 to +2. Mutation of the C in the −3 position of
the splicing acceptor site (to a G) causes DGI-II in our
kindred. Group A3 introns have a C in the −3 position
64% of the time, and a purine (G or A) for less than 6%
(Clark and Thanaraj 2002). The previously reported p.
V18F mutation which also manifests itself as DGI-II with
progressive hearing loss, changes the G in the +1 position
of the splicing acceptor sequence to a T (CAGGT–
CAGTT). A G is found in the +1 acceptor position in 49%
of human group A3 introns, making it plausible that the p.
V18F mutation (g.1191G→T) may also diminish the
ability of the splicing machinery to delete intron 2.
About 15% of human genetic diseases are caused by
point mutations at or near splice junctions (Krawczak et al.
1992; Stenson et al. 2003). Two of the eight DSPP point
mutations known to cause dominant dentin malformations
are in introns, and three of the other six mutations are in
codons adjacent to a splice junction, although only one (p.
V18F) is in a position considered important for splicing
Fig. 3 Mutation analysis of the DSPP gene. Top row Pedigree of the
proband’s family (arrow proband). Affected members are shaded.
The 11 family members willing to participate in the study are
numbered. Second row SSCP analysis of intron 2/exon 3 showed
that the intron 2 mutation (red arrowhead) is only found in the
affected individuals (II-3, II-4, III-6, III-9, and IV-1). Third row left
DNA sequencing chromatograms of the PCR amplification of intron
2/exon 3 from a wild-type individual (above) and the proband
(below). A red arrowhead marks the position of the mutated
nucleotide. Third row right ASO hybridization of intron 2/exon 3
PCR amplification products by using mutant (top) and wild-type
(bottom) radiolabeled oligonucleotides. DNA from the four affected
(M) and four unaffected (N) recruited members of the DGI kindred
were spotted on both sides of the membrane as experimental
controls. The blots of the four affected members were the only
samples to show positive hybridization to the mutant oligonucle-
otide. Bottom row The splice acceptor site consensus sequence is
shown aligned with the intron 2/exon 3 junctions of the human
(AF163151), rat (AJ278306), and mouse (AJ002141) DSPP genes
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(Black 2003). It is not possible to biopsy human tissues
expressing DSPP mRNA, so we can only speculate the
effects that the IVS2-3C→G mutation has on RNA
splicing. Presumably, the splicing machinery cannot
process the intron 2 splice acceptor site properly. Some
transcripts derived from the mutant DSPP allele might
retain intron 2 with its multiple upstream in-frame
translation termination codons. Such transcripts might be
spliced further by the nonsense-associated alternative
splicing system, or, if transported out of the nucleus,
could be degraded by the nonsense-mediated decay
system, which detects the presence of premature stop
codons in mRNA transcripts and initiates degradation
(Maquat 2002; Moore 2002; Wagner and Lykke-Andersen
2002). In other transcripts, exon 3 might not be recognized
and might be deleted during splicing, as has been shown to
occur in other splice acceptor site mutations (Bischoff et
al. 2004). The skipping of exon 3 would maintain the
reading frame but would delete 28 amino acids (18–45)
from the DSP protein, leaving the DPP region unaltered.
Looking back at the dental phenotypes manifested by
affected individuals in the families with eight different
mutations in the DSPP gene, it is evident that there are far
more similarities than differences. The major distinction
between DGI-I and DGI-II is that DGI-I is associated with
OI and generally reflects a mutation in type I collagen. The
major distinction between DGI-II and DD-II is that the
permanent teeth in DD-II patients do not show significant
discoloration, although structural changes in secondary
dentition, such as partial obliteration of the pulp chambers,
are evident. Dean et al. (1997) have proposed that the
inherited disturbances of dentin should be classified
according to their genetic etiologies. Important benefits
might be realized from such a revision, but before a gene-
based classification system can be instituted, more
information is needed about the specific genes and
mutations that cause inherited dentin defects and about
the dental phenotypes associated with each mutation.
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